prog20170118_corresp.htm

0001437749-17-000781.txt : 20170216 0001437749-17-000781.hdr.sgml : 20170216 20170118170828 ACCESSION NUMBER: 0001437749-17-000781 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 CORRESP 1 filename1.htm prog20170118_corresp.htm

Progenics Pharmaceuticals, Inc.

One World Trade Center

New York, New York 10007

January 18, 2017

Via EDGAR

Johnny Gharib

Senior Counsel
Division of Corporation Finance

United States Securities and Exchange Commission

100 F Street N.E.
Washington, D.C. 20549-3561

Re:	Progenics Pharmaceuticals, Inc. Registration Statement on Form S-3 (File No. 333-215454)

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Progenics Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-215454) (the “Registration Statement”) be accelerated by the Securities and Exchange Commission (the “Commission”) so that the Registration Statement will become effective at 4:30 p.m., Eastern Daylight Time, on January 19, 2017, or as soon as practicable thereafter.

Please do not hesitate to contact Tobias L. Knapp, Esq. of O’Melveny & Myers LLP at (212) 408-2440 with any questions or comments with respect to this letter.

Very truly yours,

Progenics Pharmaceuticals, Inc.

By: /s/ Patrick Fabbio
Name: Patrick Fabbio
Title: Chief Financial Officer